John Overdeck’s Accretive Health AH Stock Holding History

John Overdeck’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-36,011	Closed	-$330K	–	2531
2013 Q4	$330K	Buy	+36,011	New	+$310K	﹤0.01%	1839

Other funds holding AH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

John Overdeck's AH Position: Q1 2014 in Review

John Overdeck sold out of Accretive Health (AH) in Q1 2014, closing a stake of 36,011 shares — an estimated $330K sold.

John Overdeck first reported a position in AH in Q4 2013 and held it in 1 quarter. The position peaked at $330K in Q4 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

John Overdeck reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
John Overdeck sold 36,011 Accretive Health shares in Q1 2014, an estimated $330K.
John Overdeck first reported a position in Accretive Health in Q4 2013 and held it in 1 quarter.
John Overdeck's Accretive Health position peaked at $330K in Q4 2013.
66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Two Sigma Investments's 13F filing for Q1 2014, filed 15 May 2014.